Approval · Notice of Compliance 5965 · 1994
CEFIZOX: Notice of Compliance 5965
Issued May 19, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5965
- Date
- May 19, 1994
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph, new expiration date
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFIZOX | Not yet assigned | — |
Medicinal ingredients
- CEFTIZOXIME SODIUM 2 G per VIAL
- CEFTIZOXIME SODIUM 1 G per VIAL